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Objectives The purpose of this document is to make the output of the International Working Group for Intravascular Optical
Coherence Tomography (IWG-IVOCT) Standardization and Validation available to medical and scientific commu-
nities, through a peer-reviewed publication, in the interest of improving the diagnosis and treatment of patients
with atherosclerosis, including coronary artery disease.
Background Intravascular optical coherence tomography (IVOCT) is a catheter-based modality that acquires images at a reso-
lution of 10 m, enabling visualization of blood vessel wall microstructure in vivo at an unprecedented level of
detail. IVOCT devices are now commercially available worldwide, there is an active user base, and the interest in
using this technology is growing. Incorporation of IVOCT in research and daily clinical practice can be facilitated
by the development of uniform terminology and consensus-based standards on use of the technology, interpreta-
tion of the images, and reporting of IVOCT results.
Methods The IWG-IVOCT, comprising more than 260 academic and industry members from Asia, Europe, and the United
States, formed in 2008 and convened on the topic of IVOCT standardization through a series of 9 national and
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.09.079This is an open access article under the CC BY-NC-NDinternational meetings.
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March 20, 2012:1058–72 Optical Coherence Tomography StandardsResults Knowledge and recommendations from this group on key areas within the IVOCT field were assembled to gener-
ate this consensus document, authored by the Writing Committee, composed of academicians who have partici-
pated in meetings and/or writing of the text.
Conclusions This document may be broadly used as a standard reference regarding the current state of the IVOCT imaging
modality, intended for researchers and clinicians who use IVOCT and analyze IVOCT data. (J Am Coll Cardiol
2012;59:1058–72) © 2012 by the American College of Cardiology FoundationB
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This is an open access article under the CC BY-NC-NDIntroduction
International Working Group for Intravascular
OCT Standardization and Validation
This document is the output of the International Working
Group for Intravascular OCT Standardization and Valida-
tion (IWG-IVOCT). The Working Group consists of
experts in intravascular optical coherence tomography
(IVOCT) from Asia, Europe, and the United States. The
academic and industry sectors are represented. Today, there
are a total of 260 members in the IWG-IVOCT: 60% from
academia and 40% from industry, including representation
from all current IVOCT manufacturers. The academic
membership is approximately equally split between the
United States, European Union, and Asia, with additional
members from Australia and South America.
See page 1090
IWG-IVOCT was initiated at a meeting held in Prague,
Czech Republic, on September 25, 2008, where the interna-
tional intravascular OCT community expressed the need for a
consensus document. A decision was made to go forward with
a series of meetings to attain consensus on the use of IVOCT
technology and interpretation of IVOCT images. As of the
date of this publication, a total of 9 IWG-IVOCT meetings
have been conducted (Prague [n 1], San Francisco [n 3],
Barcelona [n 1], London [n 1], Kobe [n 1], Paris [n
1] and Washington, DC [n  1]).
This document was written by the Writing Committee,
comprised of academicians who have participated in meet-
ings and/or the writing of the document. Industry members
were active participants in IWG-IVOCT, but did not
participate on the Writing Committee. The American
From *The Massachusetts General Hospital and the Wellman Center for Photo-
medicine, Boston, Massachusetts; †Erasmus Medical Center, Rotterdam, the Neth-
erlands; and the ‡Wakayama Medical School, Wakayama, Japan. Drs. Tearney,
Regar, and Akasaka are co-chairs of the International Working Group for Intravas-
cular OCT Standardization and Validation (IWG-IVOCT) and co-chairs of the
Writing Committee for this document. The IWG-IVOCT effort has been partially
sponsored by gifts and educational grants from Merck, Boston Scientific, and the
Center for Integration of Medicine & Innovative Technology. Dr. Akasaka is on the
clinical advisory board of St. Jude Medical and Terumo Inc.; and has received research
funding from Abbott Vascular Japan, St. Jude Medical Japan, Goodman Inc., and
Boston Scientific Inc. All members of the Writing Committee, as well as their
affiliations and relationships with industry, are listed in the Online Supplementary
Material.m
Manuscript received February 28, 2011; revised manuscript received August 9,
2011, accepted September 27, 2011.College of Cardiology Task Force on Clinical Expert
Consensus Documents did not commission this work.
Purpose of This Document
IVOCT is an emerging imaging technology for evaluating
the cross-sectional and 3-dimensional (3D) microstructure of
blood vessels at a resolution of approximately 10 m.
ecause of its higher resolution than intravascular ultra-
ound (IVUS), IVOCT may be capable of characterizing
he superficial structure of the vessel wall in greater detail.
s a result, it is believed that IVOCT may become an
mportant imaging technique for medical fields that involve
athological assessment of blood vasculature, including
ardiology. In order to facilitate uniform use and adoption
f this technology, the IWG-IVOCT has worked collab-
ratively to generate standard nomenclature, usage guide-
ines, image interpretation criteria, measurement method-
logy, and reporting of IVOCT results. This consensus
ocument is the output of this effort, intended for research-
rs and clinicians who use IVOCT and analyze IVOCT
ata. Because the vast majority of knowledge about IVOCT
ertains to the coronary arteries, this document focuses on
oronary application of IVOCT. This document will be
onsidered current until subsequently revised by IWG-
VOCT.
ethodology
ifferent IWG-IVOCT subgroups were formed to address
he main topic areas within the IVOCT field. Each sub-
roup was tasked with summarizing: 1) what is known to
ate; 2) common pitfalls or roadblocks; and 3) what is not
nown to date within their respective topic area. In addi-
ion, the subgroups were asked to provide recommendations
r guidelines regarding what are currently thought to be
cceptable approaches for each topic. Information was
btained from each of the subgroups and assembled by the
WG-IVOCT organizers to provide a draft consensus
ocument, which was then circulated to the Writing Com-
ittee for review and editing. Comments were also solicited
rom the entire IWG-IVOCT during the internal review
rocess.
The format of this document is patterned closely after the
merican College of Cardiology Clinical Expert Consensus
ocument on Standards for Acquisition, Measurement,
nd Reporting of Intravascular Ultrasound Studies by Mintz
t al. (1), hereinafter termed JACC IVUS Consensus Docu-
ent. Because of the similarities between IVUS and
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Optical Coherence Tomography Standards March 20, 2012:1058–72IVOCT, whenever possible, ter-
minology and methods that exist
for IVUS have been adopted for
IVOCT. For pathological de-
scriptions, the nomenclature and
classification scheme follows that
of Virmani et al. (2), when ap-
plicable.
For this document, the quality
of evidence supporting the find-
ings of the image interpretation
IWG-IVOCT subgroup is as
follows:
Evidence level: High. Homo-
geneous evidence from multiple,
well-designed, cohort (descrip-
tive) trials, each involving a num-
ber of samples to be of sufficient
statistical power or multiple his-
topathologic correlative studies
of sufficient statistical power.
Evidence level: Medium. From
at least 1 well-designed trial, in-
volving a number of samples to
be of sufficient statistical power
or a single histopathologic cor-
relative study of sufficient statis-
tical power.
Evidence level: Low. Evidence
based on clinical experience, de-
scriptive studies, or reports of
expert committees or histopatho-
logic correlative case studies.
Levels of Evidence Bibliography
A bibliography listing of representative papers that support
image interpretation levels of evidence is provided in the
Online Supplementary Material (Online Table 1).
Physical Principles of OCT Imaging
OCT is a light-based imaging modality that generates
high-resolution cross-sectional images of tissue microstruc-
ture (3). The underlying concept of OCT is analogous to
that of ultrasound; by measuring the delay time of optical
echoes reflected or backscattered from subsurface structures
in biological tissues, structural information as a function of
depth within the tissue can be obtained.
IVOCT light is in the near infrared (NIR) range, typically
with wavelengths of approximately 1.3 m, which are not
isible to the human eye. OCT measures the time delay of
he light that is reflected or backscattered from tissue, and
hat is collected by the catheter, by using a technique known
s interferometry. Light from the OCT system is split so that
portion of it travels to the patient (sample arm) through a
atheter and another portion travels a predetermined dis-
Abbreviations
and Acronyms
CSA  cross-sectional area
DICOM  Digital Imaging
and Communication in
Medicine
EEM  external elastic
membrane
FD-OCT  frequency-
domain optical coherence
tomography
IEM  internal elastic
membrane
IVOCT  intravascular
optical coherence
tomography
IVUS  intravascular
ultrasound
IWG-IVOCT  International
Working Group on
Intravascular Optical
Coherence Tomography
Standardization and
Validation
NIR  near-infrared
OCT  optical coherence
tomography
TCFA  thin-capped
fibroatheroma
TD-OCT  time-domain
optical coherence
tomographyance (reference arm). After being reflected from tissue andollected by the catheter, the sample arm light is combined
ith the reference arm light and detected by a detector.
hen the distance that the sample and reference arm lights
ave traveled are roughly equivalent, a pattern of high and
ow intensities are detected, known as interference. This
nterference pattern is analyzed by the OCT system to
etermine the amount of backscattering as a function of
elay time or depth within the tissue (A-line). A cross-
ectional IVOCT image is obtained by recording A-lines as
he beam is scanned across the sample by rotating the optics
n the catheter. The axial range over which an OCT image
an be obtained is termed the ranging depth. This parameter
ypically ranges from 4 to 6 mm. For circular images in
VOCT, the total width of the image is twice this value, or
to 12 mm in diameter.
There are 2 types of IVOCT systems: earlier time-domain
CT (TD-OCT) and more recent Fourier-domain OCT sys-
ems, also known as frequency domain OCT (FD-OCT), swept-
ource OCT, or optical frequency domain imaging (OFDI). The
ain difference between TD-OCT and FD-OCT systems
s that FD-OCT systems are capable of obtaining A-lines at
uch higher imaging speeds, facilitating rapid, 3D pullback
maging during the administration of a nonocclusive flush of
n optically transparent media such as Lactated Ringer’s or
adiocontrast.
Like IVUS, IVOCT image quality is in part dependent
n spatial resolution. Spatial resolution, or the minimum
istance between closely spaced objects that can be inde-
endently detected by the imaging system, has 2 directions:
xial (parallel to the light beam) and lateral or transverse
perpendicular to the light beam). The axial resolution for
CT is dependent on the spectral bandwidth, or range of
avelengths in the light source, and is typically approxi-
ately 10 m. Near the tip of the catheter, light is focused
by a small lens and directed toward the vessel wall. The light
converges to a minimum diameter spot (focus) outside the
catheter and then diverges. The focal location is typically 1
to 3 mm outside the catheter’s sheath. The lateral resolution
of the OCT image is best at the focus, where the diameter,
d, of the spot is at a minimum, d0, typically between 20 and
40 m. The depth of focus is twice the Rayleigh range
zr  d⁄22⁄, defined as the axial distance away from the
focus where the spot diameter increases by 2. The
iameter of the beam a given axial distance, z, from the focal
ocation is given by:
d d01  zzr
2
The spot size, and therefore the lateral resolution and the
image quality, are poorer in the portions of the image that
are distant from the focal location. Moreover, objects that
are distant from the focus may appear larger than
expected. In addition to the spot diameter, the number of
A-lines in the image can also affect lateral resolution
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March 20, 2012:1058–72 Optical Coherence Tomography Standardsalong the circumferential or rotational dimension. If there
are not enough A-lines acquired per focused spot, then
mall or closely spaced objects may not be able to be
esolved in the OCT image. The focus also affects the
ntensity of the OCT image, which has a stronger OCT
ntensity at the focus and weaker OCT intensity away
rom the focus.
Refractive index is a property of a material that governs
he speed of light through the material. Because the speed of
ight is slower in flushing media and tissue than it is in air,
he distances in the images need to be corrected for this
elay. IVOCT manufacturers provide a correction for re-
ractive index by dividing the distance in the axial direction
n the IVOCT image by the estimated refractive index of
he flushing media and tissue. Once corrected, the images
ay be used to obtain area and length measurements. The
ore precisely the refractive indices are known, the more
ccurate the measurements. Future research to determine
he refractive index of different transparent media, flushing
edia, and various tissue types will improve measurement
ccuracies.
As a light beam encounters a boundary between 2 tissues
ith different refractive indices (optical impedances), a
ortion of the light is scattered, and a portion is transmitted.
VOCT measures light that is reflected or backscattered
rom the interface and is collected by the catheter. The
mount of backscattered light, and therefore the intensity of
he OCT image, is dependent on the magnitude of the
ifference in refractive indices of the tissues. For larger
lanar structures with dimensions that are large compared
ith the wavelength of light, such as stent struts, the
eflected light is higher when the object is perpendicular to
he direction of the optical beam.
Contrast affects the quality of the image and is related to
he difference in backscattered intensities that distinguish an
bject from other objects and the background. Dynamic
ange is the difference between the minimal and maximal
eflected signals that can be detected or visualized by the
CT system. The typical dynamic range of OCT systems
anges from 30 to 50 dB (103 to 105). OCT instruments are
ften characterized by sensitivity, which is a parameter
escribing how faint a backscattered signal can be detected,
nd is typically in the range of –90 to –110 dB (10–9
to 10–11).
Penetration depth is a term that defines how deeply within
tissue one can obtain OCT image data that are higher
background noise. As the light passes through the tissue, it
is attenuated by scattering and absorption. The predominant
form of attenuation encountered by IVOCT systems that
have wavelengths near 1.3 m is scattering. Highly atten-
uating tissue, such as lipid, has a low penetration depth, and
therefore, IVOCT does not see as deeply within some
lipid-containing plaques. Other tissues, such as collagen and
calcium, have lower attenuation, and as a result, IVOCT
can see deeper into these tissues (Online Table 2). For this
reason, the penetration depth in arteries depends on tissuetype and usually ranges from 0.1 to 2.0 mm using typical
IVOCT NIR light. IVOCT cannot image through blood
because blood attenuates the IVOCT light before it reaches
the artery wall. As a result, IVOCT images are acquired as
blood is flushed from the field of view.
Equipment for IVOCT Imaging
IVOCT consoles, catheters, and Digital Imaging and Com-
munication in Medicine (DICOM) supplement 151 are
described in the Online Supplementary Material.
IVOCT Artifacts
Recognition of artifacts is critical for proper interpretation
of IVOCT images. A complete listing of the artifacts seen
in IVOCT images, as identified by IWG-IVOCT, is
described (including Online Figs. 2 to 11) in the Online
Supplementary Material.
IVOCT Image Display Techniques
There are various ways to display the IVOCT image data,
and these display techniques may affect image interpreta-
tion. Descriptions of IVOCT image display methods are
presented in the Online Supplementary Material.
Image Acquisition Protocols
Concomitant medication, patient, and lesion selection
Like IVUS, current practice requires that the patients be
anticoagulated, typically with heparin, before inserting the
guidewire into the coronary artery. If it is not contraindi-
cated, image acquisition should be conducted after the
administration of intracoronary nitroglycerin to minimize
the potential for catheter-induced vasospasm.
For patients who have severely impaired left ventricular
function or those presenting with significant hemodynamic
compromise, IVOCT should be performed with caution,
because IVOCT is conducted while clearing blood from the
field of view by flushing the artery with crystalloid/
radiocontrast media. Furthermore, IVOCT should be used
with caution in patients with a single remaining vessel or
those with markedly impaired renal function or known
allergy to the flushing media.
In lesions with coexisting rich collateral blood flow or
cases in which coaxial positioning of the guiding catheter
into the coronary ostium is not feasible, and as a conse-
quence blood clearance is insufficient, wire-type IVOCT
combined with a proximal occlusion balloon may be useful
to obtain clear IVOCT imaging.
In lesions with near complete stenosis or total occlusion
of an artery, it is recommended that, if clinically indicated,
the antegrade blood flow be restored before IVOCT exam-
ination of that artery in order to allow the flushing media to
adequately clear blood from the artery.
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Optical Coherence Tomography Standards March 20, 2012:1058–72Because the profile of the guide wire catheter, ImageWire
(available for TD-OCT only at the time of writing this
document), is smaller than that of drive cable type catheters
typically used for FD-OCT (0.014-inch or 1.1-F vs.
2.4-F to 3.2-F), clinical application of these devices may be
different. The imaging procedure for FD-OCT is more
likely to be straightforward than for TD-OCT (see the
following text). However, for vessels with severe stenosis,
FD-OCT catheters with larger profiles are sometimes
difficult or unable to pass through severely narrowed lesions
(i.e., calcified or diffusely obstructed lesions).
Image Acquisition Techniques
As with IVUS, IVOCT interrogation can be conducted via
a manual or via motorized pullback (1). Because NIR light
is unable to penetrate through blood, the field of view must
be cleared from blood during image acquisition. Several
techniques have been developed to clear blood from the
artery in order to obtain high-quality images of the artery
wall. Because the imaging and pullback speeds of FD-OCT
systems are much higher than those of TD-OCT systems,
approaches for clearing blood from the artery may differ for
the 2 systems. In this section, we describe widely used image
acquisition techniques for each type of IVOCT system.
TD-OCT image acquisition techniques. There are 2
approaches for TD-OCT image acquisition: the occlusive
technique and the nonocclusive technique. Both of these
TD-OCT image acquisition methods remove blood from
the artery using a transparent media flush and use helical
pullback imaging, but the occlusive technique mandates the
inflation of a balloon proximal to the imaging site. To date,
most TD-OCT has been performed using the occlusive
technique, but improvements in the acquisition speeds of
TD-OCT systems have allowed nonocclusive flushing to be
used as an alternative image acquisition method. The
nonocclusive flushing technique is also applied in cases in
which the occlusion balloon cannot be effectively deployed
to limit native coronary flow, such as for ostial coronary
lesions. Nonocclusive flushing may cause less myocardial
ischemia than the proximal balloon occlusion approach and
avoids a potential risk of vessel injury by proximal balloon
occlusion. Both TD-OCT image acquisition methods are
detailed in the Online Supplementary Material.
FD-OCT image acquisition techniques. Because of its
higher imaging speed, helical pullback image acquisition
with FD-OCT is primarily conducted with nonocclusive
flushing techniques for removing blood from the artery. A
detailed description of FD-OCT image acquisition proto-
cols is presented in the Online Supplementary Material.
Safety Data
TD-OCT. In a multicenter registry including 468 patients
imaged with the occlusive flush or nonocclusive flush
technique, the most frequent events were transient chest
pain and electrocardiogram changes (QRS widening/ST-
segment depression/elevation), observed in 47.6% and (45.5% of cases, respectively. Major complications included 5
cases (1.1%) of ventricular fibrillation due to balloon occlu-
sion and/or deep guide catheter intubation, 3 cases (0.6%) of
air embolism, and 1 case (0.2%) of vessel dissection. There
were no cases of coronary spasm or major adverse coronary
events during or within the 24-hour period after TD-OCT
examination (4).
FD-OCT. One clinical paper reported no serious electrocar-
iogram changes or complications with FD-OCT imaging
sing the nonocclusive flush technique (5). In preliminary
egistries of patients imaged with FD-OCT, the most
requent events were transient T-wave inversion or ST-
egment depression, observed in 10% of cases (6). No major
omplications during or within the 24-h period after FD-
CT examination were observed (6).
ualitative Assessment
efinition of Lesion and Reference Segment
he definitions of Lesion and Reference Segment from
ACC IVUS Consensus Document have been adopted for
VOCT. These definitions are presented with modifications
ext:
roximal reference. The site with the largest lumen prox-
mal to a stenosis but within the same segment (usually
ithin 10 mm of the stenosis, with no major intervening
ranches). This may not be the site with the least plaque.
istal reference. The site with the largest lumen distal to
stenosis but within the same segment (usually within 10
m of the stenosis, with no intervening branches). This
ay not be the site with the least plaque.
argest reference. The largest of either the proximal or
istal reference sites.
Average reference lumen size: the average value of lumen
ize at the proximal and distal reference sites.
esion. A lesion is seen by IVOCT as a mass lesion within
he artery wall, focal intimal thickening, or loss of the
ayered intima, media, adventitia architecture.
tenosis. A stenosis is a lesion that compromises the lumen
y at least 50% by cross-sectional area (CSA), as compared
ith a predefined reference segment lumen.
orst stenosis (T-1). The stenosis with the smallest
umen size.
econdary stenoses (T-2, T-3, and so on). Lesions meet-
ng the definition of a stenosis, but with lumen sizes larger
han the worst stenosis.
lood
ecause blood attenuates light and can affect the quality of
he IVOCT image, it should be recognized in the images.
lood has high superficial backscattering and has high
ttenuation below the surface (Evidence Level: High).
hen mixed with optically transparent flushing media, it
ay form many different patterns within the artery lumenOnline Fig. 8). Blood can be confused with red thrombus.
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March 20, 2012:1058–72 Optical Coherence Tomography StandardsCare should be taken when interpreting plaque components
through blood, as blood can shadow the IVOCT signal.
Lesion Morphology
Like IVUS, IVOCT images are fundamentally different
from histology. However, owing to the higher, 10-m
resolution of IVOCT, images obtained using IVOCT share
some similarities with histological images. The capability of
IVOCT to detect and quantify specific contents that are
analogous to histological features may therefore be possible
in some circumstances. As a result, pathological descriptors
have been used in this document, with the classification and
nomenclature following that of Virmani et al. (2). We note
that not all features capable of being identified by histology
have been verified to also be seen by IVOCT, so caution
must be taken when applying histological descriptors to
IVOCT images. The extent to which IVOCT can describe
pathology has yet to be determined.
Consensus was achieved as follows on qualitative image
interpretation pertaining to single cross-sectional image
diagnosis. Because most implementations of IVOCT obtain
multiple sequential images during pullback, seeing a feature
in more than 1 frame improves diagnostic confidence.
Normal vessel wall or intimal thickening. The normal
vessel wall is characterized by a layered architecture, com-
prising a highly backscattering or signal-rich intima (thin),
a media that frequently has low backscattering or is signal-
Figure 1 Normal Artery Wall
Normal artery wall shows a 3-layered architecture, comprising a high backscat-
tering, thin intima, a low backscattering media, a heterogeneous and/or high
backscattering adventitia, IEM (green arrow), and EEM (yellow arrow) (inset,
2). Scale bars represent 500 m. EEM  external elastic membrane; IEM 
internal elastic membrane; IVOCT  intravascular optical coherence tomogra-
phy. *Guide-wire artifact. IVOCT technology, image contributor and institution,
and commercial IVOCT vendor for each figure is provided in the Online Supple-
mentary Material.poor, and a heterogeneous and frequently highly backscat-
tering adventitia (Evidence Level: High) (Fig. 1). The
periadventitial tissues may contain IVOCT data consistent
with adipocytes, characterized by large clear structures resem-
bling cells and/or vessels. With IVOCT, the internal elastic
membrane (IEM) is defined as the border between the intima
and media, and the external elastic membrane (EEM) is
defined as the border between the media and the adventitia.
On occasion, these interfaces may be visualized as highly
backscattering thin structures bordering the intima-media
(green arrow) or media-adventitia (yellow arrow) interfaces,
respectively (Fig. 1, inset).
Atherosclerotic plaque or atheroma. An atherosclerotic
plaque is defined as a mass lesion (focal thickening) or loss of
a layered structure of the vessel wall (Evidence Level: High).
For some plaques, the adventitia, EEM, deep edge of the
intima, and/or IEM may be identified (Fig. 2A), whereas for
others, these features may not be seen due to the attenuation of
light as it is transmitted through plaque tissues (Fig. 2B).
Fibrous plaque. A fibrous plaque (Figs. 2A and 2B) has
high backscattering and a relatively homogeneous IVOCT
signal (Evidence Level: High). Sometimes the IEM or
EEM may be identified in fibrous plaques (Fig. 2A).
Caution should be exercised when characterizing a lesion as
fibrous plaque if the IEM or EEM cannot be identified.
Sometimes, the limited penetration depth of IVOCT does
not allow the accurate detection of deep signal-poor areas
possibly representing necrotic core or calcium behind fi-
brous tissue. Fibrous plaques by IVOCT may be composed
of collagen or smooth muscle cells. Although it has been
postulated that proteoglycans and type III collagen have a
lower OCT signal intensity, the relationship between the
OCT signal and type III collagen and proteoglycans has not
yet been established.
Fibrocalcific plaque. A fibrocalcific plaque contains
IVOCT evidence of fibrous tissue (defined previously),
along with calcium that appears as a signal-poor or heter-
ogeneous region with a sharply delineated border (leading,
trailing, and/or lateral edges) (Evidence Level: High) (Figs.
2C and 2D). This definition applies for larger calcifications;
the IVOCT appearance of small calcifications, including
microcalcifications, has not been established.
Necrotic core. A necrotic core by IVOCT is a signal-poor
region within an atherosclerotic plaque, with poorly delin-
eated borders, a fast IVOCT signal drop-off, and little or no
OCT signal backscattering, within a lesion that is covered
by a fibrous cap (Evidence Level: Low) (Fig. 3). The
necrotic core may also contain IVOCT evidence of choles-
terol crystals. It is important to note the distinction between
signal-poor regions of calcium, which have sharply delin-
eated borders, as opposed to signal-poor regions of necrotic
core, which have poorly defined or diffuse borders. Caution
must be exercised when diagnosing necrotic core deep in the
tissue, as the attenuation of the IVOCT signal may present
as a signal-poor region. As such, IVOCT may be more
accurate for identifying necrotic cores that are close to the
1064 Tearney et al. JACC Vol. 59, No. 12, 2012
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macrophages, which have a high attenuation, may reside at the
surface of a plaque and generate the appearance of a signal-
poor region below. Artifacts, such as tangential signal dropout
(Online Fig. 10), blood, or red thrombus, may also create the
appearance of a necrotic core, when one is not actually present.
It is recommended that studies be performed ex vivo to
correlate IVOCT findings with histopathologic determination
of necrotic core that is devoid of collagen matrix. Because light
does not penetrate well through the necrotic core, it was
generally agreed that IVOCT is not capable of measuring the
thickness, area, or volume of necrotic cores when the EEM
cannot be identified.
IVOCT histopathologic correlative studies have been con-
ducted, showing a good correspondence between signal-poor
IVOCT regions with poorly defined or diffuse borders and a
broader histopathologic category known as “lipid pool” (Evi-
dence Level: High). In these studies, a lipid pool corresponds
histologically to either a necrotic core or a region within
pathological intimal thickening that contains extracellular lipid
Figure 2 Fibrous and Fibrocalcific Plaques
(A) Fibrous plaque with IEM (green arrow) and EEM (yellow arrow). (B) Plaque w
be visualized opposite to the main lesion. (C) Fibrocalcific plaque showing circumf
plaque with focal calcific deposit comprising regions with sharply delineated borde
delineated borders, suggestive of lipid (yellow arrows). Scale bars represent 500
dor for each figure is provided in the Online Supplementary Material. *Guide-wire aor proteoglycans. At present, there are no definitive publishedstudies directly comparing IVOCT lipid pool–containing
plaques with necrotic core by histology, and as a result, the
Evidence Level was determined to be Low for IVOCT
delineation of necrotic core. Nevertheless, there are multiple
studies demonstrating that these lesions are more commonly
found at the culprit site in patients with acute coronary
syndrome and acute myocardial infarction, compared with
patients with stable angina.
Fibrous cap. A fibrous cap is a tissue layer, which is often
signal-rich, overlying a signal-poor region (Evidence Level:
High) (Fig. 3). Whether or not the cap is signal-rich or
signal-poor and the implications of IVOCT intensity gray-
scale values of the cap remains an open question.
Fibroatheroma. As follows from the preceding descriptions,
a fibroatheroma is a lesion with an IVOCT-delineated fibrous
cap and a necrotic core (Evidence Level: Low).
OCT thin-capped fibroatheroma. An OCT thin-capped
fibroatheroma (OCT-TCFA) is defined as an IVOCT-
delineated necrotic core with an overlying fibrous cap where
the minimum thickness of the fibrous cap is less than a
IEM or EEM (white arrow). The EEM (yellow arrow) and IEM (green arrow) can
l signal-poor heterogeneous region with well-delineated borders. (D) Mixed
sistent with calcium (red arrow), and adjacent signal-poor areas with poorly
OCT technology, image contributor and institution, and commercial IVOCT ven-
. Abbreviations as in Figure 1.ithout
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cutoff minimal cap thickness for TCFA include 65 m (7);
however, these cutoffs should be adjusted when applied to
IVOCT images, accounting for the 10% to 20% tissue
shrinkage that can occur during histopathologic processing.
On the basis of clinical experience and supportive clinical
studies, the consensus was that the OCT-TCFA was
related to the histopathologic definition of a TCFA. Some
studies have used an additional parameter that the necrotic
core should subtend an arc that is greater than 90° or
comprise more than 1 quadrant of an image displayed in
Cartesian coordinates. The number of quadrants or the arc
angle threshold for OCT-TCFA remains an open question.
Recommendations were made to conduct future ex vivo
studies to correlate IVOCT findings with angular extent.
Care should be taken when delineating OCT-TCFA due to
the susceptibility of interpreting artifacts as necrotic core
(Online Supplementary Material).
Macrophage accumulations. Macrophages may be seen by
IVOCT as signal-rich, distinct, or confluent punctate re-
Figure 3 Fibroatheroma
(A) Low IVOCT signal (yellow arrows) with poorly delineated borders and a cap
eated regions can be seen in more than 3 quadrants circumferentially (yellow
low backscattering (yellow arrows) and a thin fibrous cap (red arrow). (D) OCT
(red arrow). Scale bars represent 500 m. IVOCT technology, image contributo
Online Supplementary Material. *Guide-wire artifact. Abbreviations as in Figuregions that exceed the intensity of background speckle noise LEvidence Level: Medium) (Fig. 4). Macrophages should
nly be evaluated in the context of a fibroatheroma, as no
acrophage validation studies have been reported to date on
ormal vessel wall or intimal hyperplasia. Macrophages may
ften be seen at the boundary between the bottom of the cap
nd the top of a necrotic core. Macrophages attenuate the
VOCT light significantly, and as a result, superficial
acrophages can shadow underlying tissue, giving it the
ppearance of a necrotic core. Macrophage accumulations
ay also be confused on occasion with microcalcifications,
holesterol crystals, or internal or external elastic membrane.
oting the linear appearance of the cholesterol crystals or
aminae can minimize some of these misinterpretations. It
hould be noted that high axial and lateral resolutions are
esired for detection of macrophage accumulations.
hether or not IVOCT can identify individual macro-
hages is not known.
ntimal vasculature. Vessels within the intima can appear
s signal-poor voids that are sharply delineated and can
sually be followed in multiple contiguous frames (Evidence
n arrow) characterize this fibroatheroma. (B) Signal-poor and poorly delin-
s). C. OCT thin-capped fibroatheroma (TCFA) lesion that shows regions with
that shows low backscattering (yellow arrow) covered by a thin fibrous cap
institution, and commercial IVOCT vendor for each figure is provided in the(gree
arrow
-TCFA
r and
1.evel: Low) (Fig. 5A). It is not known whether these vessels
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from the vasa vasorum and whether there is a threshold for
the size of these vessels within the intima.
Figure 4 Macrophage Accumulations
Macrophage accumulations appear as confluent or punctate highly backscattering
ated by visualizing the images using an inverse gray scale look-up table (right col
(yellow arrow). Lower-row panels are 2-magnified versions of upper-row pane
and commercial IVOCT vendor for each figure is provided in the Online Supplementar
Figure 5 Intimal Vasculature and Cholesterol Crystals
(A) Intimal vessels are well-delineated regions or voids with low IVOCT backscatte
tures within in the plaque (arrows). Scale bars represent 500 m. IVOCT technolo
vided in the Online Supplementary Material. *Guide-wire artifact. Abbreviations as in FCholesterol crystals. Cholesterol crystals by IVOCT may
appear as thin, linear regions of high intensity, usually associ-
ated with a fibrous cap or necrotic core (Evidence Level: Low)
egions within the artery wall (red arrows), which may be more readily appreci-
Macrophage accumulations can cause shadowing of underlying tissue structure
le bars represent 500 m. IVOCT technology, image contributor and institution,
rial. *Guide-wire artifact. Abbreviations as in Figure 1.
rrows). (B) Cholesterol crystals appear as linear, highly backscattering struc-
age contributor and institution, and commercial IVOCT vendor for each figure is pro-
.focal r
umn).
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sometimes be seen. Although some cholesterol crystals may be
seen by IVOCT, sometimes they are not visualized; the
reasons for this are not currently understood. The capability of
IVOCT to reliably detect cholesterol crystals merits future
research.
Thrombus. Thrombus by IVOCT appears as a mass at-
tached to luminal surface or floating within the lumen
(Evidence Level: High). When imaging without pullback,
some thrombi may be seen to be moving in real-time.
IVOCT is capable of discriminating 2 types of thrombus:
red (red blood cell–rich) thrombus (Fig. 6A), which is
highly backscattering and has a high attenuation (resembles
blood), and white (platelet-rich) thrombus (Fig. 6B), which
is less backscattering, is homogeneous, and has low atten-
uation. A small thrombus may be confused with a small
dissection or intimal disruption. Thrombus may shadow or
obscure underlying structures. Red thrombi may be misin-
terpreted as necrotic core fibroatheroma. The appearance of
organized thrombus by IVOCT is hypothesized to be
heterogeneous, but the image characteristics of organized
thrombus are not well understood or validated. The capa-
bility of IVOCT to identify fibrin as a standalone tissue
constituent remains an open question.
Mixed lesions. It is important to note that a single IVOCT
cross-sectional or L-mode image may contain regions that show
IVOCT features that are characteristic of multiple plaque types
(e.g., Fig. 2D). These plaques are sometimes also called
heterogeneous plaques or mixed lesions.
Dissections and Complications After Intervention
IVOCT definitions of dissections subsequent to interven-
tion largely follow the conventions of the JACC IVUS
Figure 6 Thrombi
(A) Red thrombus. Yellow arrow points to a red thrombus protruding into the lume
points to white thrombus with homogeneous backscattering and low attenuation, a
stent strut malapposition in this image. Scale bars represent 500 m. IVOCT tech
is provided in the Online Supplementary Material. *Guide-wire artifact. AbbreviatioConsensus Document and are described in the Online
Supplementary Material.
Unstable Lesions and Ruptured Plaque
The TCFA has been associated with plaque rupture and
coronary thrombosis at autopsy. No natural history studies
have been performed to definitively demonstrate that OCT-
TCFAs are associated with future risk for a coronary event.
However, these lesions have been found in greater frequency in
patients with acute coronary syndrome and acute myocardial
infarction, as compared with patients with stable angina.
Reports have also shown that these OCT-TCFAs can rupture
and thrombose. Macrophages have also been shown to be
correlated with symptom severity. Future natural history stud-
ies should be conducted to demonstrate the risk of OCT-
TCFAs and macrophage-rich plaques for enabling the iden-
tification of patients at higher risk for future coronary events.
Ruptured plaques. Ruptured plaques frequently occur in
the context of OCT-TCFAs and show features of intimal
tearing, disruption, or dissection of the cap (Evidence Level:
High) (Fig. 7A). When injected with optically transparent
crystalloid or radiocontrast media, these defects may have
little or no IVOCT signal and may appear as a cavity.
Plaque ulceration. Plaque ulceration is defined as in JACC
IVUS Consensus Document as “A recess in the plaque
beginning at the luminal-intimal border” (Evidence Level:
Medium).
OCT erosion. Erosions may be composed of IVOCT
evidence of thrombus, an irregular luminal surface, and no
evidence of cap rupture evaluated in multiple adjacent
frames (Evidence Level: Low) (Fig. 7B).
Calcific nodule. A calcific nodule is defined as a single or
multiple regions of calcium (defined previously) that pro-
high IVOCT backscattering and attenuation. (B) White thrombus. White arrow
d to the surface of coronary artery involving stent struts. There is extensive
, image contributor and institution, and commercial IVOCT vendor for each figure
in Figure 1.n with
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angles (Evidence Level: Low).
Thrombus. Thrombus may be identified as white (Figs. 6B
and 7A) or red thrombi (Fig. 6A). Thrombi may be sufficiently
arge to obscure the underlying rupture site or luminal defect.
nusual Lesion Morphology
VOCT definitions for true aneurysm, pseudoaneurysm,
nd true versus false lumen follow the definitions set forth in
he JACC IVUS Consensus Document and are presented in
he Online Supplementary Material.
tent Assessment
ecause metal stent struts are opaque to light, only the first
leading) surface of individual struts is visualized by
VOCT. The opacity of metal struts also causes a shadow
hat obscures deeper structures within the vessel wall. The
efinitions of different parameters of interest for the assess-
ent of stents are as follows:
rolapse. Prolapse is defined as the projection of tissue into
he lumen between stent struts after implantation (Fig. 8A)
Evidence Level: High). Prolapse is more frequently observed
hen the stent is placed over an OCT-TCFA or necrotic core. It
ay be difficult to differentiate between prolapse, thrombus,
ntimal, and intra-stent dissection and neointima.
pposition. Apposition of the stent struts to the arterial
all can be seen by IVOCT because of its high resolution
nd capability to identify the tissues surrounding the struts
Evidence Level: High). Malapposition is present when the
xial distance between the strut’s surface to the luminal
urface is greater than the strut thickness (including poly-
er, if present) (Fig. 8B). If the distance is less than the
trut thickness, then the strut is considered apposed. Two
Figure 7 Plaque Rupture and Erosion
(A) Plaque rupture. Arrow delineates a broken fibrous cap. The contents of the ru
arrow). (B) Plaque erosion. A white thrombus (white arrow) is present on an irreg
IVOCT technology, image contributor and institution, and commercial IVOCT vendo
Abbreviations as in Figure 1.orms of apposition have been described in the literature: Irotruding, where the endoluminal strut boundary is located
bove the level of the luminal surface, and embedded, where
he endoluminal strut boundary is below the level of the
uminal surface; however, the clinical significance of this
lassification is unclear. It is important to note that before
ssessing apposition, it is necessary to calibrate the distance
nd include appropriate corrections for refractive index.
pposition can be described on a per-strut, a per–cross-
ectional area, and a per-stent basis.
hrombus. Thrombus is frequently identified in target le-
ions and can protrude in-between or over stent struts (Evi-
ence Level: High) (Fig. 6B). The previously described classifi-
ation scheme for red and white thrombus remains valid.
issections. Dissections at the edge of stents are frequently
een by IVOCT (Evidence Level: High) (Figs. 8C and 8D).
he classification scheme for dissections is described in the Online
upplementary Material.
CT strut coverage. The high-resolution capabilities of
VOCT and also its diminished susceptibility to artifacts at
he stent strut interface compared with IVUS make it
apable of visualizing tissue overlying struts. This capability
as been used to evaluate the response to stent implantation.
truts are termed covered by IVOCT if tissue can be
dentified above the struts (Fig. 9A). Struts are dubbed
ncovered by IVOCT if no evidence of tissue can be
isualized above the struts (Fig. 9B, green inset). There are
are observations where struts may have tissue covering only
art of the strut; some experts considered the strut to be
lassified as covered in these cases, whereas others suggested
hat these struts be classified as having incomplete coverage.
t present, IVOCT has not been shown to allow the
isualization of endothelium, but this question is still under
nvestigation. In order to not confuse strut coverage by
plaque are partially washed away by the flush, leaving behind a cavity (white
minal surface. There is no evidence of rupture. Scale bars represent 500 m.
ch figure is provided in the Online Supplementary Material. *Guide-wire artifact.ptured
ular lu
r for eaVOCT with histopathologic determination of endothelial
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strut coverage be used. Additionally, the precise nature of
tissue coverage has not been demonstrated, be it fibrin,
endothelium, thrombus, neointimal, or other. It has been
postulated that IVOCT strut coverage tissue characteristics
such as backscattering intensity may provide further dis-
crimination of IVOCT strut coverage tissue type (8);
however, it was believed that this topic merited further
investigation. In addition, the significance of the intensity of
the strut’s backscattering has not been established. As with
apposition, strut coverage has been reported on a per-strut,
per–cross-sectional area basis, or per stent area or volume.
Restenosis. Restenosis by IVOCT may be visualized as
signal-poor (Fig. 9C), layered, or signal-rich (Fig. 9D)
tissue overlying stent struts. The relationship between the
signal intensity of restenosis seen by IVOCT and the
underlying tissue composition has only been documented in
rare cases and is not generally understood.
Bioabsorbable stents/scaffolds. Depending on the type of
material and the progress/process of strut degradation and
resorption, the amount of backscattering detected from the
Figure 8 Prolapse, Malapposition, and Dissections
(A) Tissue prolapse. Arrows delineate tissue that has prolapsed between stent struts
the artery wall. (C) A small dissection at edge of stent (yellow arrows). (D) A larger d
tor and institution, and commercial IVOCT vendor for each figure is provided in the Onstruts and the underlying vessel wall will vary. At present,definitions for resorbable struts have been proposed by
Ormiston et al. (9) (preserved box, open box, dissolved
bright box, and dissolved black box) for one type of
bioabsorbable scaffold. It was further noted that the appear-
ances of bioabsorbable struts by IVOCT depends on the
scaffold material and the time point of visualization.
Special Considerations
IVOCT serial examinations of atheroma progression/
regression, interventional target lesion assessment, and serial
examination of stents are described in the Online Supple-
mentary Material.
Quantitative Measurements
Measurements should be made on good-quality images that do
not contain artifacts. In order to make accurate measurements,
the image should be correctly calibrated for z-offset and
refractive index. Studies have been published regarding the
accuracy of IVOCT measurements and the reproducibility of
tent malapposition showing stent struts that are distant from the luminal surface of
on (white arrow). Scale bars represent 500 m. IVOCT technology, image contribu-
pplementary Material. *Guide-wire artifact. Abbreviations as in Figure 1.. (B) S
issecti
line Suderived qualitative and quantitative parameters (10–12).
m
d
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A description of methodologies used to delineate the
borders of the lumen, EEM, and IEM, plaque constituents,
and stent and stent struts is provided in the Online
Supplementary Material.
In IVUS, it can be difficult to demarcate the IEM and for
this reason the EEM is typically used to define the deep
boundaries of plaque. In contrast, for IVOCT, either or
both the IEM or EEM may be visualized and, therefore,
plaque measurements may be computed from either the
IEM or EEM when present in the image. Measurements
that use the EEM are likely closer to those of IVUS,
whereas measurements that use the IEM more closely
approximate the pathologic definition of atherosclerosis as a
disease of the intima.
Atheroma Measurements
Lumen measurements. Once the lumen has been traced, the
lumen measurements performed by IVOCT are similar to that
for IVUS and are reproduced for completeness from the JACC
IVUS Consensus Document here:
Figure 9 Covered and Uncovered Stent Struts and Restenosis
(A) Covered stent struts. IVOCT signal around and covering stent struts varies. (B
inset (yellow, 2) shows struts with overlying tissue. Lower inset (green, 2) dep
demonstrate a blooming artifact (yellow arrows, green inset). (C) In-stent resteno
neous, high-backscattering neointima. Scale bars represent 500 m. IVOCT techn
is provided in the Online Supplementary Material. *Guide-wire artifact. Abbreviatio“LUMEN CSA. The area bounded by the luminal border.MINIMUM LUMEN DIAMETER. The shortest diameter through
the center of mass of the lumen.
MAXIMUM LUMEN DIAMETER. The longest diameter through
the center of mass of the lumen.
LUMEN ECCENTRICITY. (maximum lumen diameter minus
inimum lumen diameter) divided by maximum lumen
iameter.
LUMEN AREA STENOSIS. (Reference lumen CSA minus min-
imum lumen CSA) divided by reference lumen CSA. The
reference segment used should be specified (proximal, distal,
largest, or average—see above). Post-intervention (if dissec-
tion is present), it is important to state whether the lumen
area is the true lumen or a combination of the true and false
lumens.”
IEMmeasurements. For plaques in which the IEM can be
identified, the preceding lumen measurements can be made
for the IEM, including the IEM CSA. In addition, the
following measurements, modified from the JACC IVUS
Consensus Document can be made for plaques in which the
red (yellow dotted box) and uncovered (green dotted box) stent struts. Upper
ruts with no apparent overlying tissue coverage. Some of the uncovered struts
th a low IVOCT signal intensity. (D) In-stent restenosis demonstrating a homoge-
image contributor and institution, and commercial IVOCT vendor for each figure
in Figure 1.) Cove
icts st
sis wi
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lumen CSA.
MAXIMUM PLAQUE (OR ATHEROMA) THICKNESS. The largest
istance from the intimal leading edge to the IEM along any
ine passing through the center of mass of the lumen.
MINIMUM PLAQUE (OR ATHEROMA) THICKNESS. The shortest
distance from intimal leading edge to the IEM along any
line passing through the luminal center of mass.
PLAQUE (OR ATHEROMA) ECCENTRICITY. (Maximum plaque
thickness minus minimum plaque thickness) divided by
maximum plaque thickness.
PLAQUE (OR ATHEROMA) BURDEN. Plaque CSA divided by the
IEM CSA. The atheroma burden is distinct from the luminal
area stenosis. The former represents the area within the IEM
occupied by atheroma regardless of lumen compromise. The
latter is a measure of luminal compromise relative to a reference
lumen analogous to the angiographic diameter stenosis.
REMODELING. An index of remodeling can be assessed per
he JACC IVUS Consensus Document, modified for the
EM (lesion IEM CSA/reference IEM CSA).
It should be noted that the aforementioned IEM measure-
ents can also be measured for the EEM, if it is identified in
he IVOCT image. It is therefore recommended that when
eporting these measurements, the use of either IEM or EEM
e clearly specified. These measurements furthermore should
ot be made in cross-sectional images that contain artifacts
hat obscure a significant portion ( 90°) of the image or over
egions that contain side branches.
laque, plaque component, and thrombus measure-
ents. Plaque components including fibrous tissue, lipid
ool, necrotic core, cap, calcium, and macrophage accumu-
ations are segmented or outlined by procedures described in
he Online Supplementary Material.
ANGLE. Arc measured using the center of mass of the lumen
as the angle point.
DEPTH. The distance between the lumen and the leading
edge of the plaque feature.
THICKNESS. The thickest distance between the inner and
uter surfaces of the plaque component (valid only if the
eep boundary can be identified).
AREA. The CSA of the plaque component (valid only if the
deep boundary can be identified).
CAP THICKNESS. Defined as the thickness of a cap present
over IVOCT-delineated calcium or necrotic core. Although
studies have been performed to compare the IVOCT
measurement of fibrous cap thickness with histologic mea-
surements of cap thickness, it was generally considered that
this area needs further validation, as the boundary between
the cap and the necrotic core is not always straightforward
to precisely determine.MACROPHAGE ACCUMULATION MEASUREMENTS. Quantita-
tive measurements of the high signal and heterogeneity of
macrophage accumulations have been estimated using a pa-
rameter termed the normalized standard deviation (13). Care
ust be taken to smooth out speckle noise before applying this
arameter. Limitations of this parameter include the fact that
issue without macrophages have a non-zero normalized stan-
ard deviation because of the inherent tissue microstructure.
he capability of IVOCT to visualize macrophage accumula-
ions and other inflammatory components in the vicinity of
tent struts has not been documented.
tent Measurements
ithin stented segments, IVOCT allows for measurements
hat are analogous to IVUS. Although the IVUS approach
s valid in principle, IVOCT measurements in practice differ
s follows: 1) The IVOCT stent measurement field is at a
elatively early stage; 2) IVOCT stent measurements can be more
emanding due to the greater amount of microstructural
etail visible by IVOCT; 3) a variety of methods are
urrently used; and 4) the clinical significance of some
VOCT-derived stent measurements is unknown. As a
esult of these differences, it has been recommended that the
WG-IVOCT continue to deliberate and document stent
easurement methods until comprehensive consensus
ethodology is uniformly agreed upon. Parameters de-
cribed next represent consensus definitions at the time of
ublication of this document.
tent area measurements. Consensus IVOCT quantita-
ive stent area measurements follow that of the JACC IVUS
onsensus Document, modified in part here:
STENT CSA. The area bounded by the stent border.
MINIMUM STENT DIAMETER. The shortest diameter through
the center point of the stent.
MAXIMUM STENT DIAMETER. The longest diameter through
he center point of the stent.
STENT ECCENTRICITY. (Maximum stent diameter minus
inimum stent diameter) divided by maximum stent
iameter.
STENT CSA STENOSIS (STENT PERCENT AREA OBSTRUCTION,
NEOINTIMA BURDEN). (Stent CSA minus lumen CSA)/stent
SA.
IEM NEOINTIMAL AREA. (IEM CSA minus lumen CSA)/IEM
CSA. This parameter can only be defined when the IEM
can be delineated.
Stent strut measurements. STRUT MALAPPOSITION DIS-
TANCE. Distance between the abluminal surface of the strut
and the luminal surface of the artery wall. Some investigators
have estimated the location of the abluminal surface of the strut
by drawing a line from the luminal surface of the strut toward
the artery wall, where the line has a length that is equivalent to
the known strut plus polymer (if present) thickness. The end of
this line is an estimate of the location of the abluminal surface
l
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contour of the vessel, the strut is considered to be malapposed.
OCT STRUT COVERAGE THICKNESS. Distance between the
uminal surface of the covering tissue and the luminal
urface of the strut. IVOCT is capable of measuring the
issue overlying a strut within the resolution of the OCT
ystem. The biological and clinical significance of OCT
trut tissue coverage thickness that is measured to be less
han, equal to, or near the axial resolution of the OCT
ystem is not well understood.
PERCENTAGE OF UNCOVERED STENT STRUTS. The number of
struts without distinct overlying tissue, in which the luminal
reflection of the strut surface is directly interfacing with the
lumen, divided by total number of analyzable struts. This
assessment is limited by the axial resolution of the IVOCT
system and by blooming artifacts, which can be pronounced
with metallic stents.
Length and Volume Measurements
Methodologies for measuring length and volume in IVOCT is
presented in the Online Supplementary Material.
IVOCT Validation
Methods for validating IVOCT image interpretation crite-
ria and quantitative measurements are important for future
application of this technology. Recommendations for
ex vivo, animal model, and phantom validation and corre-
lation with other imaging modalities are presented in the
Online Supplementary Material.
Specialized Techniques
A description of specialized OCT techniques, including
polarization-sensitive OCT and Doppler OCT, is provided
in the Online Supplementary Material.
Reporting of IVOCT Studies
Reporting of IVOCT studies closely follows that recom-
mended in the JACC IVUS Consensus Document, as
described in the Online Supplementary Material.
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APPENDIX
Expanded information for this article, including the Online Supplementary
Material, additional tables, figures, technical glossary, figure credits, and
a list of Writing Committee members with their affiliations and relation-
ships with industry, are online.
